Skip to content Skip to sidebar Skip to footer
Subscribe Now
Viewpoint_Brain Finrow_2020
VIEWPOINTS
PharmaShots Interview: Lumen’s Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19
In an interview with PharmaShots, Brian Finrow, Co-Founder and CEO of Lumen Bioscience shared his views on the critical need for a scalable and cheaper method to engineer antibodies as a potential treatment for Covid-19. He also shed light on why it is time for the industry to reevaluate plant-based biologics manufacturing as a possible way to…
June 26, 20200Comments
Thoughtspot_Dr. Anish Desai
THOUGHTSPOT
How Will the MedTech Industry Navigate The COVID-19 Impact?
COVID-19 has casted the healthcare community into disarray. Healthcare providers are stressed as the disease has affected more people than the production capacity of healthcare companies to manufacture ventilators, personal protective equipment (PPE) and diagnostic kits. Since Business disruptions have happened, business continuity strategies are in operation. The medical technology (Medtech) industry is moving swiftly…
June 22, 20200Comments
Diagnostics Companies Based Top 20 2019
TOP 20
Top 20 Diagnostics Companies Based on 2019 Revenue
Diagnostics has emerged as one of the largest and fastest-growing segments with evolving diseases. The segment has played a vital role in diagnosing growing and ageing global population with increasing health expenditure and more prevalent lifestyle ailments including obesity- cancer- and cardiovascular diseases. Our team at PharmaShots has compiled a list of top 20 diagnostics companies based…
June 12, 20200Comments
Insights+ Key Biosimilars Events of May 2020
INSIGHTS+
Insights+ Key Biosimilars Events of May 2020
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Fresenius Kabi expanded its footprints with the acceptance of MAA and BLA of its MSB11455 (biosimilar, pegfilgrastim) in the EU and the US respectively, and also signed an agreement with Medec to commercialize Idacio (adalimumab, biosimilar) in…
June 5, 20200Comments